Access cutting-edge multiple sclerosis treatment through this clinical trial at a research site in Stamford. Study-provided care at no cost to qualified participants.
Access multiple sclerosis specialists in Stamford at no cost
This study follows strict safety protocols and ethical guidelines
All study-related multiple sclerosis treatment provided free
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)
Sponsor: Novartis Pharmaceuticals
Check if you qualify for this multiple sclerosis clinical trial in Stamford, CT
If you're searching for multiple sclerosis treatment options in Stamford, CT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Stamford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple sclerosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.